Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 106 participants.

Also called NCT06197022

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 106 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06197022
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Bulgaria (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06197022. Non-randomized; no masking; primary purpose treatment. Start 2022-10-01 (actual); primary completion 2024-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)
Acronym
SCA-DEB
Intervention (Device)
Mozec™ SEB Sirolimus Eluting Rx PTCA Balloon Dilatation Catheter
Lead sponsor
University National Heart Hospital (class: other)
Collaborator
Meril Life Sciences Pvt. Ltd. (class: industry)

Record details

Record id
cardio:ct-nct06197022
Content hash
08702c1592a58dc66b2b9b43900d0c595dcf5629f8e661d298e73fb972cfc75a